MedTrace Logo

Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections

NCT04897971 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-04-03

No results posted yet for this study

Summary

The goal of this study is to test a new way to diagnose and track treatment of spine infections caused by the bacteria Staphylococcus aureus.

Conditions

  • Staphylococcus Aureus Infection
  • Surgical Site Infection
  • Orthopedic Procedures
  • Spine

Interventions

DIAGNOSTIC_TEST

Medium enriched for newly synthesized antibodies in spine infection

Medium enriched for newly synthesized antibodies titers in patients with Staphylococcus aureus infections of orthopedic spine implants at baseline and in the post operative period

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Cheryl L Ackert-Bicknell, PhD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-24
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04897971 on ClinicalTrials.gov